Varshosaz Jaleh, Hassanzadeh Farshid, Sadeghi-Aliabadi Hojjat, Firozian Farzin
Department of Pharmaceutics, Novel Drug Delivery Systems Research Center, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan 81745-359, Iran.
Department of Medicinal Chemistry, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran.
Biomed Res Int. 2014;2014:708593. doi: 10.1155/2014/708593. Epub 2014 Feb 10.
Targeted drug delivery using folate receptors is one of the most interesting chemotherapeutic research areas over the past few years. A novel folate targeted copolymer was synthesized using dextran stearate coupled to folic acid. FT-IR and NMR spectroscopy were used to confirm successful conjugation. Micelles prepared using this copolymer were characterized for their particle size, zeta potential, critical micelle concentration (CMC), drug loading capacity, and release efficiency. Cytotoxicity and cellular uptake of the micelles were estimated using CT-26 colorectal carcinoma cell line. FT-IR and NMR spectroscopy confirmed production of folate grafted dextran stearate copolymer. Low CMC value indicates that the copolymers are suitable for preparation of stable micelles useful in parenteral dosage forms. Particle size and zeta potential of the targeted nanoparticles were 105.5 ± 2.0 nm and -21.2 mV, respectively. IC50 of etoposide loaded in folate grafted dextran stearate enhanced about 20-fold compared to the pure drug (0.49 ± 0.11 μg/mL versus 9.41 ± 0.52 μg/mL). It seems that etoposide loaded in micelles of folate grafted dextran stearate copolymer is promising in reducing drug resistance of colorectal cancer by boosting etoposide cellular uptake.
利用叶酸受体进行靶向给药是过去几年中最受关注的化疗研究领域之一。通过将硬脂酸葡聚糖与叶酸偶联合成了一种新型的叶酸靶向共聚物。采用傅里叶变换红外光谱(FT-IR)和核磁共振光谱(NMR)来确认偶联成功。对使用该共聚物制备的胶束进行了粒径、zeta电位、临界胶束浓度(CMC)、载药量和释放效率等方面的表征。使用CT-26结肠癌细胞系评估了胶束的细胞毒性和细胞摄取情况。FT-IR和NMR光谱证实了叶酸接枝硬脂酸葡聚糖共聚物的生成。低CMC值表明该共聚物适用于制备可用于肠胃外剂型的稳定胶束。靶向纳米颗粒的粒径和zeta电位分别为105.5±2.0 nm和-21.2 mV。与纯药物相比,负载在叶酸接枝硬脂酸葡聚糖中的依托泊苷的半数抑制浓度(IC50)提高了约20倍(分别为0.49±0.11μg/mL和9.41±0.52μg/mL)。似乎负载在叶酸接枝硬脂酸葡聚糖共聚物胶束中的依托泊苷有望通过提高依托泊苷的细胞摄取来降低结肠癌的耐药性。